Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle Grant Type Focus Area Country Application Due Date Shared Decision Making in Hemophilia Patient CareRelease Date:Quality Improvement Rare Disease China Optimizing Care for patients with Muscle Invasive Bladder Cancer (MIBC)Release Date:Quality Improvement Oncology Canada Optimizing HRRm Testing and Workflow Integration in mCSPCRelease Date:Quality Improvement, Research Oncology Canada Antimicrobial Stewardship —Treatment optimization under antibiotics appropriate use policy in ChinaRelease Date:Research Inflammation & Immunology China Optimizing Antimicrobial Stewardship (AMS) Interventions and Outcomes in Clinical Outcomes, Optimal Use and Resource UtilizatioRelease Date:Research Inflammation & Immunology China Driving Timely Biomarker Testing to Optimize Treatment Decisions for Colorectal Cancer Patients Across CanadaRelease Date:Partner: Colorectal Cancer Canada (CCC)Quality Improvement, Research Oncology Canada Optimizing Disease Management to Improve Alopecia Areata Quality of CareRelease Date:Quality Improvement Inflammation & Immunology China Research on Exploring Disease Assessment and Prioritizing Systematic Treatment for VitiligoRelease Date:Research Inflammation & Immunology China Quality Improvement in Molecular Testing Pathways for Metastatic Colorectal Cancer (mCRC)Release Date:Partner: American Society for Clinical Pathology (ASCP)Quality Improvement Oncology USA Personalized monitoring&treatment for HR+, HER2- mBC patients treated w CDK4/6i: incorporating Patient complexity risk factorsRelease Date:Quality Improvement, Research Oncology Italy Title Grant Type Focus Area Country Application Due Date Programs Toward Improving the Quality of Depression TreatmentRelease Date:Improving Patient Care in Inflammatory Bowel Disease (IBD) through Shared Decision-MakingRelease Date:Review Process:Developing Clinical Research and Publication Skills - AfME and EURelease Date:Review Process:Developing Clinical Research and Publication Skills – UKRelease Date:Review Process:Inflammatory Bowel Disease FellowshipsRelease Date:Improving Health Outcomes in Atopic Dermatitis (AD) through Shared Decision-MakingRelease Date:Review Process:Patient Decision Aids for Inflammatory ConditionsRelease Date:Review Process:Improving Assessment and Treatment of Acute Vaso-occlusive CrisisRelease Date:Rheumatology FellowshipRelease Date:Review Process:Developing Clinical Research and Publication Skills – UK (Re-release)Release Date:Review Process:Developing Clinical Research and Publication Skills - AfME and EU (Re-release)Release Date:Review Process:Dermatology FellowshipRelease Date:Review Process: